Testing effectiveness (Phase 2)Study completedNCT00140348What this trial is testingDose Escalation and Efficacy Trial of GVAX® Prostate Cancer VaccineWho this might be right forProstate Cancer Cell Genesys 80
Testing effectiveness (Phase 2)Study completedNCT01314118What this trial is testingIMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific AntigenWho this might be right forProstate CancerProstatic Neoplasm Janssen Biotech, Inc. 131
Not applicableStudy completedNCT01833208What this trial is testingRadiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-TWho this might be right forHormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more Roswell Park Cancer Institute 15
Not applicableActive Not RecruitingNCT04030338What this trial is testingProstate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerWho this might be right forProstate CancerProstate NeoplasmProstate Adenocarcinoma+2 more Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00284752What this trial is testingPhase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate CancerWho this might be right forProstate Cancer Kaiser Permanente 56
Large-scale testing (Phase 3)Study completedNCT04887506What this trial is testingTAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate CancerMetastatic Castration-sensitive Prostate CancerMetastatic Prostate Cancer Tavanta Therapeutics 107
Testing effectiveness (Phase 2)Ended earlyNCT05551117What this trial is testingVobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsWho this might be right forCastration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more MacroGenics 192
Not applicableUnknownNCT03381326What this trial is testingCTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.Who this might be right forProstate CancerMetastatic CancerCastration-resistant Prostate Cancer+1 more Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 104
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Not applicableNot Yet RecruitingNCT06430411What this trial is testingOutcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyWho this might be right forProstate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more Medical University of Vienna 500
Testing effectiveness (Phase 2)Study completedNCT03204812What this trial is testingDurvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forCastration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneProstate Adenocarcinoma+3 more M.D. Anderson Cancer Center 31
Not applicableLooking for participantsNCT06652607What this trial is testingPSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate CancerWho this might be right forProstate CancerMetastatic CancerCastrate Sensitive Prostate Cancer Fondazione Policlinico Universitario Agostino Gemelli IRCCS 152
Not applicableLooking for participantsNCT06700057What this trial is testingClinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.Who this might be right forProstate CancerMetastasis Institut Bergonié 50
Not applicableUnknownNCT02940977What this trial is testingEstablishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection TechniqueWho this might be right forProstatic NeoplasmsProstatic Adenoma Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05422911What this trial is testingAbiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.Who this might be right forMetastatic CancerNeoplasm, Prostate James J. Peters Veterans Affairs Medical Center 200
Early research (Phase 1)Study completedNCT01325558What this trial is testingALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced Malignant NeoplasmMalignant Solid Tumour Altor BioScience 30
Testing effectiveness (Phase 2)Study completedNCT00174863What this trial is testingEvaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate CancerWho this might be right forProstatic Neoplasm Sanofi 232
Testing effectiveness (Phase 2)Study completedNCT00271687What this trial is testingA Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate CancerWho this might be right forProstatic NeoplasmsNeoplasm MetastasisPalliative Care AHS Cancer Control Alberta 30
Testing effectiveness (Phase 2)Study completedNCT02105675What this trial is testingPhase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerWho this might be right forProstate CancerProstate Cancer Metastatic SOTIO a.s. 60
Early research (Phase 1)Looking for participantsNCT06778863What this trial is testingCLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationWho this might be right forAdvanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more Clasp Therapeutics, Inc. 90